Abbott Drug Eluting Coronary Stents
Closed State & local contract opportunity Posted
- Solicitation number
- 2136447
- State
- New York
- Responses due
Opportunity facts
- Jurisdictions
- Points of contact
-
- Jessica Gruzo jessica.gruzo@sbumed.org (631) 444-4051
- Michael Assante michael.assante@stonybrook.edu (631) 444-4326
Updated .
About this opportunity
Stony Brook University Hospital intends to purchase Abbott Drug Eluting Coronary Stents from a single-source contract awarded under New York State Finance Law section 163(3)(vi), which permits procurement from a consortium or comparable entity without formal competitive process when justified by price; proposals are due July 13, 2026. Vendors manufacturing equivalent products may contact the designated officer to discuss participation.
This procurement is not a competitive solicitation. The hospital is exercising statutory authority to procure directly or through an existing contract vehicle. Compliance with New York State Finance Law 139 j&k (Lobbying Law) is mandatory — vendors may communicate only with the designated officer, and failure to comply can result in contract rejection or debarment from all New York State Agency sales. Successful contractors must submit Vendor Responsibility documentation, Finance Law 139 certifications, Tax Law Section 5-a compliance, and current Workers' Compensation and Disability Forms.
Abbott Laboratories Inc. was awarded an identical or substantially similar contract within the past five years and holds incumbent status. The procurement covers Drug Eluting Coronary Stents and related deliverables as defined by the hospital's clinical and supply-chain requirements. Place of performance spans Suffolk County and Syracuse City.
Opportunity text
Stony Brook University Hospital intends to purchase Abbott Drug Eluting Coronary Stents from a contract awarded pursuant to their authority under section 163(3)(vi), which authorizes the purchase of commodities from a consortium or comparable entity in lieu of using a centralized contract and without a formal competitive process when justified by price. Vendors who sell or manufacture the equivalent products may, if interested, contact the Officer listed below to discuss the procurement. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract to debarment from sales to any NYS Agency. Successful contractor shall be required to complete and submit documents related to Vendor Responsibility, NYS Finance Law 139, NYS Tax Law Section 5-a, and valid/current NYS Workers' Compensation and Disability Forms. If you propose to submit a bid, it must be received by COB of the due date listed below. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: Abbott Laboratories Inc.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity